• Pamela Duffy Named Among Top 100 Lawyers in California by Daily Journal

    Coblentz is proud to announce that Pamela Duffy was selected as one of Daily Journal’s Top 100 – California’s Leading Attorneys of 2011. The list, an honor of excellence, recognizes the 100 elite lawyers across all practices in California – men and women who are making the most impact on the legal profession and on society right now. Ms. Duffy was among 18 women selected for this distinguished list.
    Click here to download the document

    Categories: News
  • Coblentz Lawyers Named to Annual Super Lawyers List

    15 Coblentz partners have been recognized by Law and Politics as 2011 Northern California Super Lawyers. Super Lawyers selects attorneys using a rigorous, multiphase rating process. Peer nominations and evaluations are combined with third party research. Each candidate is evaluated on 12 indicators of peer recognition and professional achievement. Selections are made on an annual, state-by-state basis. The final published list represents no more than 5 percent of the lawyers in the state. Super Lawyers is a comprehensive and diverse listing of outstanding attorneys representing a wide range of practice areas, firm sizes and geographic locations.

    Pamela Duffy was also named to the distinguished list of the Top 50 Women Lawyers, and as one of the Top 100 Lawyers in Northern California. She has been recognized since 2004 by Super Lawyers.

    Click here to view the complete list of Coblentz lawyers who are named in the 2011 list.

    Categories: News
  • Coblentz Counsels Client Open SystemC Initiative in Formation of a Single Organization with Accellera

    Paul Tauber served as counsel to Open SystemC Initiative (OSCI) in negotiations to form a single organization with Accellera. The two industry organizations are focused on the creation and adoption of electronic design automation (EDA) and intellectual property (IP) standards, and recently signed a memorandum of understanding, beginning the process of combining the groups in order to create more comprehensive standards to benefit the worldwide electronic design community, and facilitate efficient collaboration among their members.

    Categories: News
  • Paul Tauber Seals Chronix Biomedical’s License Agreement with Myriad Genetics for Early Cancer Detection Technology

    Paul Tauber served as lead counsel for Chronix Biomedical in solidifying an exclusive license agreement with Myriad Genetics to commercialize Chronix’s early cancer detection technology. Chronix is extremely pleased with the closing of this significant deal, one that will ultimately progress Chronix’s proprietary technology and tests.

    Chronix Biomedical has pioneered a breakthrough approach to the diagnosis, monitoring and management of a broad range of cancers and other conditions through proprietary technology that measures and categorizes DNA sequences circulating in the blood that are associated with specific changes in disease and health status. Myriad Genetics, Inc., is a leading molecular diagnostic company dedicated to developing and marketing novel predictive, personalized and prognostic medicine products to assess a person’s risk of developing disease and guide treatment decisions.

    “We are pleased with the partnership of our technology with Myriad Genetics given their expertise in developing and commercializing molecular diagnostic products,” said Dr. Howard Urnovitz, Chief Executive Officer of Chronix Biomedical. “The technology we have licensed from Chronix Biomedical has the potential to revolutionize the early detection of cancer through the analysis of unique DNA sequences in blood samples,” said Mark Capone, President of Myriad Genetic Laboratories, Inc.

    Under the terms of the agreement, Myriad has exclusive rights in North America, South America, and Europe to commercialize tests developed from the Chronix Biomedical technology for the early detection of breast, colon, and prostate cancer. In turn, Myriad will help validate these tests and will pay Chronix an undisclosed sum in upfront fees, milestone payments, and royalty payments upon the technical and commercial success of the products. The success of the development and commercialization of these early detection cancer tests could end up being a highly profitable investment for Myriad and a significant authentication for Chronix.

    Categories: News
  • Coblentz client projects win awards in San Francisco Business Times “Real Estate Deals of the Year”

    Here is the complete list of the winners and finalists and their categories recognized in the San Francisco Business Times 2010 Real Estate Deals of the Year Awards:

    Winner of Office Lease/Sublease for San Francisco: Zynga.

    Winner of Residential Market-Rate for San Francisco: One Hawthorne.

    Winner for Rehab/Renovation: Presidio Landmark.

    Finalist for Infrastructure/Public-Private: Exploratorium.

    Categories: News
  • Coblentz’s Business Practice Wins Finance Monthly Law Award

    The 2011 Finance Monthly Law Awards recognizes firms that have dedicated their resources to innovation, built on their depth of expertise and have performed outstandingly over the year. Finance Monthly sent a voting ballot to over 36,000 contacts resulting in this distinction for Coblentz’s Business Practice.

    Categories: News
  • Danna Kozerski Named as a 2011 Dealmaker of the Year by Daily Journal

    Danna Kozerski was named a 2011 Dealmaker of the Year. The Daily Journal selected Danna as one of 20 California real estate attorneys whose complex real estate deals had a significant impact on local communities and the real estate market, and also demonstrated creativity, adaptability and tenacity.

    Three of Kozerski ‘s 2010 accomplishments earned her the award: a 157,000 square-foot lease negotiation with Nokia Inc. on behalf of the landlord at the Sunnyvale Town Center; a lease of 270,000 square feet at the Townsend Center to Zynga Game Network Inc. (the largest San Francisco lease in five years) on behalf of TMG Partners; and the complex 66-year lease for the Exploratorium’s new home on Piers 15 and 17 in a public/private partnership financial transaction.

    Categories: News